TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT
Clinical trials for TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT explained in plain language.
Never miss a new study
Get alerted when new TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT trials appear
Sign up with your email to follow new studies for TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot helps diabetics shed pounds in major trial
Disease control OngoingThis study tests a new medication, maridebart cafraglutide, to see if it helps adults with type 2 diabetes who are overweight or obese lose more weight than a placebo. About 1,100 participants will receive either the drug or a placebo for 72 weeks. The main goal is to measure the…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Handheld scanners and glucose monitors aim to catch diseases early
Diagnosis ENROLLING_BY_INVITATIONThis study tests whether portable ultrasound and blood glucose monitors can help doctors catch chronic conditions like diabetes, heart disease, and kidney disease earlier than usual. About 200 adults will use these devices or receive standard care for 6 months. The goal is to see…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM), OBESITY, OVERWEIGHT
Phase: EARLY_PHASE1 • Sponsor: Truway Health, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC